Robert Connelly

Insider Reports History

Location
Jerusalem, Israel
Signature
/s/ Robert Connelly
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Connelly:

Company Role Class Num Shares Value Price $ Report Date Ownership
Elicio Therapeutics, Inc. CEO, President and Director, Director Common Stock 120,570 $959,737 $7.96 02 Feb 2026 Direct
Elicio Therapeutics, Inc. CEO, President and Director, Director Stock Option (Right to Buy) 147,200 02 Feb 2026 Direct

Insider Reports Filed by Robert Connelly

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ELTX Elicio Therapeutics, Inc. 02 Feb 2026 2 $0 4 CEO, President and Director, Director 03 Feb 2026, 16:42
ELTX Elicio Therapeutics, Inc. 03 Feb 2025 1 $0 4 CEO, President and Director, Director 04 Feb 2025, 16:08
ELTX Elicio Therapeutics, Inc. 30 Sep 2024 1 $0 4 CEO, President and Director, Director 02 Oct 2024, 16:14
ELTX Elicio Therapeutics, Inc. 01 Feb 2024 1 $0 4 CEO, President and Director, Director 05 Feb 2024, 06:01
ELTX Elicio Therapeutics, Inc. 01 Jun 2023 0 $0 3 CEO, President and Director, Director 07 Jun 2023, 21:37